Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 101–200 of 1,020
Sex, body mass index, and dietary fiber intake influence the human gut microbiome
Dominianni, C., Sinha, R., Goedert, J. J., Pei, Z., Yang, L., Hayes, R. B., & Ahn, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124599 · Cited by 468
“Furthermore, since obesity is a significant risk factor of many chronic diseases [52,53], including colorectal cancer [54], these findings may also point to potentially harmful microbes.”
BackgroundAssessing the Human Gut Microbiota in Metabolic Diseases
Karlsson, F., Tremaroli, V., Nielsen, J., & Bäckhed, F. (2013) · Diabetes · doi:10.2337/db13-0844 · Cited by 452
“The incidence of type 2 diabetes (T2D) is increasing in parallel with obesity, and environmental factors that are associated with T2D risk include diet and the gut microbiota (28).”
Neyrinck, A. M., Possemiers, S., Druart, C., Van de Wiele, T., De Backer, F., Cani, P. D., Larondelle, Y., & Delzenne, N. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020944 · Cited by 465
The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Forbes, J. D., Van Domselaar, G., & Bernstein, C. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01081 · Cited by 429
“While a breakdown in the equilibrium of the intestinal milieu may be widely recognized, perturbations surrounding biological mechanisms driving dysbiosis exist and it is unclear whether dysbiosis manifests as a cause or consequence of disease.”
BackgroundResultResearch progress in the relationship between type 2 diabetes mellitus and intestinal flora
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., Wang, T., Luo, L., Wang, C., Wang, T., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109138 · Cited by 430
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota
Engen, P. (2015) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v37.2.07 · Cited by 436
The Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus
Lappas, M., Hiden, U., Desoye, G., Froehlich, J., Mouzon, S. H.-D., & Jawerbaum, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3765 · Cited by 442
“Although the initial stimulus triggering inflammation in pregnancy with GDM is not currently known, potential candidates include dietary and environmental factors such as caloric overload or changes in microbiota in the pregnant women (39, 214).”
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2817 · Cited by 437
“(25) The reason for the high count of Lactobacillus, a probiotic, is not clear at present.”
BackgroundRole of the intestinal microbiome in health and disease: from correlation to causation
de Vos, W. M., & de Vos, E. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00505.x · Cited by 440
Lecomte, V., Kaakoush, N. O., Maloney, C. A., Raipuria, M., Huinao, K. D., Mitchell, H. M., & Morris, M. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126931 · Cited by 418
“compared gut microbiota composition of type 2 diabetic patients and healthy volunteers; a decrease in Firmicutes phylum in individuals with diabetes and a positive correlation of Bacteroidetes to Firmicutes ratio with plasma glucose was observed [53].”
BackgroundThe microbiome: stress, health and disease
Moloney, R. D., Desbonnet, L., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Mammalian Genome · doi:10.1007/s00335-013-9488-5 · Cited by 430
Metagenome-wide association studies: fine-mining the microbiome
Wang, J., & Jia, H. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.83 · Cited by 429
Graessler, J., Qin, Y., Zhong, H., Zhang, J., Licinio, J., Wong, M.-L., Xu, A., Chavakis, T., Bornstein, A. B., Ehrhart-Bornstein, M., et al. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.43 · Cited by 428
Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., & Akbarian-Moghari, A. (2011) · Journal of Dairy Science · doi:10.3168/jds.2010-4128 · Cited by 416
“Larsen et al. (2010) reported that T2DM was associated with compositional changes in the intestinal microflora and the proportion of phylum Firmicutes was significantly reduced in human adults with T2DM compared with nondiabetic people.”
BackgroundXu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., Guo, Y., Zhang, C., Zhou, Q., Xue, Z., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2014.177 · Cited by 422
“A greater abundance of opportunistic pathogens, such as Betaproteobacteria, was found in the gut of diabetic patients compared with healthy controls (Larsen et al., 2010).”
BackgroundMicrobiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
Composition and temporal stability of the gut microbiota in older persons
Jeffery, I. B., Lynch, D. B., & O’Toole, P. W. (2016) · The ISME Journal · doi:10.1038/ismej.2015.88 · Cited by 421
“…compositional stability include microbiota alterations associated with inflammatory bowel disease (Rigottier-Gois, 2013; Gevers et al., 2014), obesity (Ley et al., 2006; Parekh et al., 2014), irritable bowel syndrome (Jeffery et al., 2012; DuPont 2014) and type 2 diabetes (Larsen et al., 2010).”
BackgroundInteraction Between Obesity and the Gut Microbiota: Relevance in Nutrition
Delzenne, N. M., & Cani, P. D. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145146 · Cited by 411
“(67) have shown a significant decrease in the Firmicutes phylum in individuals with diabetes in comparison with controls.”
ResultGomez-Arango, L. F., Barrett, H. L., Wilkinson, S. A., Callaway, L. K., McIntyre, H. D., Morrison, M., & Dekker Nitert, M. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1406584 · Cited by 402
Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview
Kampmann, U., Knorr, S., Fuglsang, J., & Ovesen, P. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5320156 · Cited by 381
Blautia genus associated with visceral fat accumulation in adults 20–76 years of age
Ozato, N., Saito, S., Yamaguchi, T., Katashima, M., Tokuda, I., Sawada, K., Katsuragi, Y., Kakuta, M., Imoto, S., Ihara, K., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0101-x · Cited by 416
Control of lupus nephritis by changes of gut microbiota
Mu, Q., Zhang, H., Liao, X., Lin, K., Liu, H., Edwards, M. R., Ahmed, S. A., Yuan, R., Li, L., Cecere, T. E., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0300-8 · Cited by 404
“microbiota of SLE individuals with a lower Firmicutes to Bacteroidetes ratio [5] that is consistent with gut dysbiosis observed in other autoimmune conditions [6, 7].”
ResultTonucci, L. B., Olbrich dos Santos, K. M., Licursi de Oliveira, L., Rocha Ribeiro, S. M., & Duarte Martino, H. S. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.011 · Cited by 381
“In addition, the gut microbiota also seems to be important to the pathophysiology of T2D [7].”
BackgroundGut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism
Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02153 · Cited by 399
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
Moszak, M., Szulińska, M., & Bogdański, P. (2020) · Nutrients · doi:10.3390/nu12041096 · Cited by 397
“[150] described the reduction in phyla Firmicutes and Clostridia and the increase in Bacteroidetes to Firmicutes ratio, as well as an increased Bacteroides-Prevotella ratio in patients with T2D.”
BackgroundGut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
“Additionally, the ratio of Bacteroidetes to Firmicutes and Bacteroides-Prevotella to Clostridium coccoides-Eubacterium was positively correlated with blood glucose levels [115].”
Wang, B., Jiang, X., Cao, M., Ge, J., Bao, Q., Tang, L., Chen, Y., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep32002 · Cited by 376
The dormant blood microbiome in chronic, inflammatory diseases
Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 383
Moreno-Indias, I., Sánchez-Alcoholado, L., Pérez-Martínez, P., Andrés-Lacueva, C., Cardona, F., Tinahones, F., & Queipo-Ortuño, M. I. (2016) · Food & Function · doi:10.1039/c5fo00886g · Cited by 373
“…Sharma et al., 1999 35 Enterobacter cloacae CGAGAGCCTGUTGCTG GAT TGGCTGACCCAAT Anbazhagan et al., 2010 36 Faecalibacterium prausnitzii GGAGGAAGAAGGTCTTCGG AATTCCGCCTACCTCTGCACT Payne et al., 2011 37 Roseburia TACTGCATTGGAAACTGTCG CGGCACCGAAGAGCAAT Larsen et al., 2010 38 Food Funct.”
BackgroundMohr, A. E., Jäger, R., Carpenter, K. C., Kerksick, C. M., Purpura, M., Townsend, J. R., West, N. P., Black, K., Gleeson, M., Pyne, D. B., et al. (2020) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00353-w · Cited by 378
Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome
Chassard, C., Dapoigny, M., Scott, K. P., Crouzet, L., Del'homme, C., Marquet, P., Martin, J. C., Pickering, G., Ardid, D., Eschalier, A., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05007.x · Cited by 363
Review of the relationships among polysaccharides, gut microbiota, and human health
Song, Q., Wang, Y., Huang, L., Shen, M., Yu, Y., Yu, Q., Chen, Y., & Xie, J. (2021) · Food Research International · doi:10.1016/j.foodres.2020.109858 · Cited by 357
Brunkwall, L., & Orho-Melander, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4278-3 · Cited by 355
“Significant differences in the composition of microbiota at the phylum level were observed between the groups using a principal component analysis [7].”
A healthy gastrointestinal microbiome is dependent on dietary diversity
Heiman, M. L., & Greenway, F. L. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.02.005 · Cited by 370
The Relationship Between Gut Microbiota and Weight Gain in Humans
Angelakis, E., Armougom, F., Million, M., & Raoult, D. (2012) · Future Microbiology · doi:10.2217/fmb.11.142 · Cited by 358
Gut microbiota: a new path to treat obesity
on behalf of the Obesity Programs of nutrition, E., Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., & Colao, A. (2019) · International Journal of Obesity Supplements · doi:10.1038/s41367-019-0011-7 · Cited by 354
The Intestinal Metabolome: An Intersection Between Microbiota and Host
Ursell, L. K., Haiser, H. J., Van Treuren, W., Garg, N., Reddivari, L., Vanamala, J., Dorrestein, P. C., Turnbaugh, P. J., & Knight, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.001 · Cited by 355
“Another powerful computational tool is Predicted Relative Metabolic Turnover, which uses gene counts to predict the relative consumption and production of metabolites in a system; it can be used for modeling and hypothesis generation.(37) Tools such as PICRUSt and Predicted Relative Metabolic Turnover could be cost-ef…”
MethodGut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
Gut microbiota, probiotics and diabetes
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363
“Studies have shown the intestinal microbiota is associated with the development of metabolic diseases, as obese and diabetic subjects present perturbations in the proportions of Firmicutes, Bacteroidetes and Proteobacterias [4,12].”
BackgroundMillion, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., & Raoult, D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.20 · Cited by 362
RetractedRETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedSu, M., Tang, T., Tang, W., Long, Y., Wang, L., & Liu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243834 · Cited by 334
“(18) found that in diabetic patients The relative abundance of Clostridia, Firmicutes was significantly reduced and Betaproteobacteria was highly enriched.”
BackgroundRole of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Jayashree, B., Bibin, Y. S., Prabhu, D., Shanthirani, C. S., Gokulakrishnan, K., Lakshmi, B. S., Mohan, V., & Balasubramanyam, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1911-4 · Cited by 353
“Interestingly, recent studies also imply a definite role and association of altered gut microbiota with the type 2 diabetes [34, 35].”
BackgroundBerberine pharmacology and the gut microbiota: A hidden therapeutic link
Habtemariam, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104722 · Cited by 352
Probiotics, prebiotics, synbiotics and insulin sensitivity
Kim, Y. A., Keogh, J. B., & Clifton, P. M. (2018) · Nutrition Research Reviews · doi:10.1017/s095442241700018x · Cited by 335
“nificantly lower in diabetic adults than in non-diabetic adults((20,21)).”
BackgroundThe effect of heritability and host genetics on the gut microbiota and metabolic syndrome
Lim, M. Y., You, H. J., Yoon, H. S., Kwon, B., Lee, J. Y., Lee, S., Song, Y.-M., Lee, K., Sung, J., & Ko, G. (2017) · Gut · doi:10.1136/gutjnl-2015-311326 · Cited by 345
Wong, V. W.-S., Tse, C.-H., Lam, T. T.-Y., Wong, G. L.-H., Chim, A. M.-L., Chu, W. C.-W., Yeung, D. K.-W., Law, P. T.-W., Kwan, H.-S., Yu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062885 · Cited by 342
The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology
Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347
Human Gut Microbiota: Repertoire and Variations
Lagier, J.-C., Million, M., Hugon, P., Armougom, F., & Raoult, D. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00136 · Cited by 329
“…(Siggers et al., 2008), Crohn’s disease (De Hertogh et al., 2006; Manichanh et al., 2006; Scanlan et al., 2006), and metabolic diseases such as type II diabetes (Larsen et al., 2010) and obesity (Ley et al., 2006b; Turnbaugh et al., 2006, 2009; Armougom et al., 2009; Santacruz et al., 2009).”
InfluentialCatalkaya, G., Venema, K., Lucini, L., Rocchetti, G., Delmas, D., Daglia, M., De Filippis, A., Xiao, H., Quiles, J. L., Xiao, J., et al. (2020) · Food Frontiers · doi:10.1002/fft2.25 · Cited by 328
“Larsen et al. (2010) identified the composition of fecal microbiota in Chinese adults with type 2 diabetes as compared to non-diabetic controls.”
BackgroundKelly, T. N., Bazzano, L. A., Ajami, N. J., He, H., Zhao, J., Petrosino, J. F., Correa, A., & He, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.309219 · Cited by 345
Sáez-Lara, M., Robles-Sanchez, C., Ruiz-Ojeda, F., Plaza-Diaz, J., & Gil, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060928 · Cited by 328
“A clear relationship has been demonstrated between T2D and compositional changes in the gut microbiota, with a lower relative abundance of Firmicutes and a higher proportion of Bacteroidetes and Proteobacteria in T2D patients [16,17].”
BackgroundJalanka-Tuovinen, J., Salonen, A., Nikkilä, J., Immonen, O., Kekkonen, R., Lahti, L., Palva, A., & de Vos, W. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023035 · Cited by 340
“but also in systemic diseases including type 2 diabetes and other metabolic diseases”
BackgroundTurroni, F., Ventura, M., Buttó, L. F., Duranti, S., O’Toole, P. W., Motherway, M. O., & van Sinderen, D. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1318-0 · Cited by 336
“Several studies have investigated possible relationships between gut microbiota composition and various diseases, such as necrotizing enterocolitis [44], type I and type II diabetes [45, 46], irritable bowel syndrome (IBD) [47, 48], atopic diseases and allergy [49], and colon cancer [50].”
BackgroundProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders
Yoo, J., & Kim, S. (2016) · Nutrients · doi:10.3390/nu8030173 · Cited by 328
“In particular, they demonstrated a considerably lower proportion of phylum Firmicutes and bifidobacteria in T2DM patients than in non-diabetic individuals [32,47].”
BackgroundMartín-Peláez, S., Fito, M., & Castaner, O. (2020) · Nutrients · doi:10.3390/nu12082236 · Cited by 330
“Regarding bacteria, there are four main phyla living in the gut microbiota (Firmicutes, Bacteroidetes, Actinobacteria, and Proteobateria) each of which contain a vast variety of bacterial strains.”
BackgroundDavis, L. M. G., Martínez, I., Walter, J., Goin, C., & Hutkins, R. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025200 · Cited by 318
Lippert, K., Kedenko, L., Antonielli, L., Kedenko, I., Gemeier, C., Leitner, M., Kautzky-Willer, A., Paulweber, B., & Hackl, E. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0184 · Cited by 323
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
Moreno-Indias, I., Cardona, F., Tinahones, F. J., & Queipo-Ortuño, M. I. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00190 · Cited by 310
“Similar changes in the composition of intestinal microbiota have also been reported in TDM2 patients (Larsen et al., 2010; Qin et al., 2012).”
ResultVallianou, N., Stratigou, T., Christodoulatos, G. S., & Dalamaga, M. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00352-2 · Cited by 316
Benedict, C., Vogel, H., Jonas, W., Woting, A., Blaut, M., Schürmann, A., & Cedernaes, J. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.10.003 · Cited by 324
“Phylum NS d2 PSD d2 V P value Firmicutes 65.8 9.6 67.2 12.5 28 0.277 Actinobacteria 20.2 11.6 21.7 14.2 28 0.277 Bacteroidetes 10.7 9.53 8.2 8.4 13 0.143 Euryarchaeota 1.12 2.76 1.34 2.74 20 0.407 Verrucomicrobia 0.813 1.75 0.839 1.49 17 0.277 Proteobacteria 0.992 1.72 0.498 0.42 15 0.204 Tenericutes 0.284 0.347 0.129…”
MethodInfluentialFrequent Replenishment Sustains the Beneficial Microbiome of Drosophila melanogaster
Blum, J. E., Fischer, C. N., Miles, J., & Handelsman, J. (2013) · mBio · doi:10.1128/mbio.00860-13 · Cited by 311
Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?
Fernández-Veledo, S., & Vendrell, J. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09513-z · Cited by 308
The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes
Devaraj, S., Hemarajata, P., & Versalovic, J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.187617 · Cited by 321
“reported that there was a significant reduction in the relative abundance of Firmicutes and Clostridia in adults with type 2 diabetes when they used the technique of deep tag-encoded sequencing (73).”
MethodYamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., & Hattori, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171521 · Cited by 314
Curtis, M. M., Hu, Z., Klimko, C., Narayanan, S., Deberardinis, R., & Sperandio, V. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.005 · Cited by 307
“…composition exist between healthy and diseased patients; however, it is not well understood if these shifts occur prior to disease or are a product of the disease (Gevers et al., 2014; Larsen et al., 2010; Peterson et al., 2008; Turnbaugh et al., 2009a; Turnbaugh et al., 2009b; Wang et al., 2009).”
Chen, Z., Radjabzadeh, D., Chen, L., Kurilshikov, A., Kavousi, M., Ahmadizar, F., Ikram, M. A., Uitterlinden, A. G., Zhernakova, A., Fu, J., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.18811 · Cited by 305
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
Khan, M. J., Gerasimidis, K., Edwards, C. A., & Shaikh, M. G. (2016) · Journal of Obesity · doi:10.1155/2016/7353642 · Cited by 295
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Targher, G., & Byrne, C. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.16 · Cited by 309
Effects of the gut microbiota on obesity and glucose homeostasis
Greiner, T., & Bäckhed, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.01.002 · Cited by 304
The gut microbiota and metabolic disease: current understanding and future perspectives
Arora, T., & Bäckhed, F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12508 · Cited by 303
The Relationship Between the Human Genome and Microbiome Comes into View
Goodrich, J. K., Davenport, E. R., Clark, A. G., & Ley, R. E. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155532 · Cited by 311
“This includes IBD (4, 5, 65, 68), obesity (4, 5, 10, 65, 68) and type 2 diabetes (5, 65, 68), all of which are also associated with alterations in the gut microbiota (16, 37, 64).”
BackgroundMutlu, E. A., Comba, I. Y., Cho, T., Engen, P. A., Yazıcı, C., Soberanes, S., Hamanaka, R. B., Niğdelioğlu, R., Meliton, A. Y., Ghio, A. J., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.04.130 · Cited by 296
Diamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308
“Finally, a very recently published study indicated that rather T2DM than obesity per se in humans, may be associated with compositional changes in gut microbiota (62).”
BackgroundShou, Y., Huang, Y., Zhu, X., Liu, C., Hu, Y., & Wang, H. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.02.086 · Cited by 303
Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003607 · Cited by 307
“tooligosaccharide*) and (gut OR obes* OR diabet* OR lipid* OR hepat* OR immune* OR metaboli*); (2) limit 1 to year 1⁄4 ‘2000–2003’; (3) limit 2 to humans.”
BackgroundZhao, N., Chen, J., Carroll, I. M., Ringel-Kulka, T., Epstein, M. P., Zhou, H., Zhou, J. J., Ringel, Y., Li, H., & Wu, M. C. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.003 · Cited by 306
Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H., & Haslberger, A. G. (2014) · Gene · doi:10.1016/j.gene.2013.11.081 · Cited by 299
“Type 2 diabetes has often been associated with lower abundance of Firmicutes, while Bacteroidetes and Proteobacteria tended to be more abundant (Larsen et al., 2010).”
BackgroundInfluentialComparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
Sedighi, M., Razavi, S., Navab-Moghadam, F., Khamseh, M. E., Alaei-Shahmiri, F., Mehrtash, A., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.038 · Cited by 304
“Researches have indicated that Gram-negative bacteria specially those belonging to the phylum Proteobacteria and Bacteroidetes possessed LPS endotoxin (metabolic endotoxemia is meaningfully related to oxidative stress, macrophage-elements and setup of inflammatory cytokines for inducing insulin resistance) were relati…”
BackgroundResultInfluentialInterindividual variability in gut microbiota and host response to dietary interventions
Healey, G. R., Murphy, R., Brough, L., Butts, C. A., & Coad, J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux062 · Cited by 292
“rectale.(55) Gut microbiota shown to be higher in abundance in individuals with T2DM include Betaproteobacteria, Desulfovibrio, and a number of Lactobacillus spp.”
Dietary polyphenols as antidiabetic agents: Advances and opportunities
Sun, C., Zhao, C., Guven, E. C., Paoli, P., Simal‐Gandara, J., Ramkumar, K. M., Wang, S., Buleu, F., Pah, A., Turi, V., et al. (2020) · Food Frontiers · doi:10.1002/fft2.15 · Cited by 305
“In addition, the ratios of Bacteroidetes to Firmicutes significantly and positively correlated with reduced glucose tolerance (Larsen et al., 2010).”
BackgroundLiu, F., Li, P., Chen, M., Luo, Y., Prabhakar, M., Zheng, H., He, Y., Qi, Q., Long, H., Zhang, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10722-2 · Cited by 297
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
“2005) and in type 2 diabetes patients (Larsen et al. 2010; Karlsson et al. 2013).”
BackgroundCasén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 289
Dietary polyphenols to combat the metabolic diseases via altering gut microbiota
Gowd, V., Karim, N., Shishir, M. R. I., Xie, L., & Chen, W. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.09.005 · Cited by 289
Angly, F. E., Dennis, P. G., Skarshewski, A., Vanwonterghem, I., Hugenholtz, P., & Tyson, G. W. (2014) · Microbiome · doi:10.1186/2049-2618-2-11 · Cited by 292
“Considering that the ratio of bacterial phyla in the gut is linked with disorders such as obesity [50], diabetes [51] and Clostridium difficile infections [52], it is important to correct for GCN to fully understand the implications of the microbiota in health and disease.”
BackgroundComposition Diversity and Abundance of Gut Microbiome in Prediabetes and Type 2 Diabetes
Sr Fellow New Mexico Center for the Advancement of Research, E., Shah, V., Lambeth, S. M., Carson, T., Lowe, J., Ramaraj, T., Leff, J. W., Luo, L., & Bell, C. J. (2015) · Journal of Diabetes and Obesity · doi:10.15436/2376-0949.15.031 · Cited by 287
“One study demonstrated that compositional changes in the intestinal micro biota were associated with T2DM compared to non-diabetic controls[16].”
BackgroundInfluentialNovel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
Napolitano, A., Miller, S., Nicholls, A. W., Baker, D., Van Horn, S., Thomas, E., Rajpal, D., Spivak, A., Brown, J. R., & Nunez, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100778 · Cited by 282
“Our finding of significant correlations between Bacteriodetes and Firmcutes abundances and levels of cholic acid and PYY suggest mechanistic drivers behind earlier reports of the correlation between Firmicutes/Bacteriodes ratios and glycemic control in T2DM subjects [55].”
ResultJiao, N., Baker, S. S., Nugent, C. A., Tsompana, M., Cai, L., Wang, Y., Buck, M. J., Genco, R. J., Baker, R. D., Zhu, R., et al. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00114.2017 · Cited by 275
Gut Microbiota Composition and Blood Pressure: The CARDIA Study
Sun, S., Lulla, A., Sioda, M., Winglee, K., Wu, M. C., Jacobs, D. R., Shikany, J. M., Lloyd-Jones, D. M., Launer, L. J., Fodor, A. A., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12109 · Cited by 282
Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
Harris, K., Kassis, A., Major, G., & Chou, C. J. (2012) · Journal of Obesity · doi:10.1155/2012/879151 · Cited by 276
“showed that 16S rDNA sequences representing the class of Bacteroidetes were slightly higher in the diabetic subjects than in nondiabetic subjects, although the difference was not statistically significant [44].”
BackgroundRole of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 270
Molinaro, A., Bel Lassen, P., Henricsson, M., Wu, H., Adriouch, S., Belda, E., Chakaroun, R., Nielsen, T., Bergh, P.-O., Rouault, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19589-w · Cited by 271
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Tomaro-Duchesneau, C., Coussa-Charley, & Rodes (2011) · Biologics: Targets and Therapy · doi:10.2147/btt.s19099 · Cited by 256
“In addition, in murine Citrobacter rodentium infections, pathogen colonization is associated with a reduced total density and a relative increase in γ-Proteobacteria.63 Furthermore, elderly patients with C. difficile-associated diarrhea demonstrate reduced numbers of Bacteroides, Prevotella, and Bifidobacteria, and a…”
Gut microbiota influence in type 2 diabetes mellitus (T2DM)
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00446-0 · Cited by 270
Murphy, E. F., Cotter, P. D., Hogan, A., O'Sullivan, O., Joyce, A., Fouhy, F., Clarke, S. F., Marques, T. M., O'Toole, P. W., Stanton, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-300705 · Cited by 272
“Indeed, Lactobacillus populations have been shown to be elevated in obese subjects(34) and subjects with diabetes.(3) In addition, vancomycin treatment of patients with infective endocarditis was associated with a significant increase in weight gain,(36) leading the authors to speculate that this may be due to the sel…”
BackgroundIntermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea
Moreno-Indias, I., Torres, M., Montserrat, J. M., Sanchez-Alcoholado, L., Cardona, F., Tinahones, F. J., Gozal, D., Poroyko, V. A., Navajas, D., Queipo-Ortuño, M. I., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00184314 · Cited by 275
“Contrary to previous observations in conditions such as obesity, type 1 and 2 diabetes or Crohn ’ s disease [18 – 21], we did not find significant differences in gut microbiota at the phylum level when comparing intermittent hypoxia and normoxia groups.”
ResultGut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges
Deng, P., & Swanson, K. S. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514002943 · Cited by 249
“Using deep tag-encoded sequencing, Larsen et al.((10)) observed a significant reduction”
BackgroundMethod
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.